Lonza | LONN - Interest Expense On Debt


Lonza reported CHF84M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 52M 2M Mar/2026
AstraZeneca USD 484M 181M Dec/2025
BASF EUR 236M 15M Dec/2025
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 7.5M 19.5M Jun/2025
Covestro EUR 33M 1000K Sep/2025
Demant DKK 398M 37M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 79M 6M Mar/2026
Geberit CHF 7.4M 300K Dec/2025
Genmab DKK 10M 27M Dec/2025
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 167M 21M Mar/2026
GN Store Nord DKK 296M 42M Dec/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Johnson Matthey GBP 75M 4M Jun/2024
Merck EUR 104M 17M Mar/2026
Novartis USD 343M 39M Mar/2026
Philips EUR 83M 26M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Sika AG CHF 78.9M 100K Dec/2025
Smith & Nephew USD 69M 1000K Dec/2025
Solvay EUR 25M 0 Dec/2025
UCB EUR 49M 29M Dec/2025